Drug Pipeline

Molnupiravir Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
6
Active Studies
6
Recruiting
2
Phase 3
4
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-02 NCT04746183
AGILE (Early Phase Platform Trial for COVID-19)		 date change Primary completion pushed: 2026-07-31 -> 2027-03-31
2026-06-02 NCT04746183
AGILE (Early Phase Platform Trial for COVID-19)		 date change Completion pushed: 2026-07-31 -> 2027-03-31
Active Studies by Phase
Phase 3
2
Phase 2
3
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04381936 Randomised Evaluation of COVID-19 Therapy Pneumonia Recruiting
NCT06667700 A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019… Coronavirus Disease (COVID-19) Recruiting
Phase 2
NCT05041907 Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early… COVID-19 Recruiting
NCT05648448 A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza Influenza Recruiting
NCT06551844 Adaptive Dengue Antiviral Platform Trial Dengue Recruiting
Phase 1/2
NCT04746183 AGILE (Early Phase Platform Trial for COVID-19) Covid19 Recruiting
Sponsors Running Molnupiravir Trials
University of Oxford (3) University of Liverpool (1) Oxford University Clinical Research Unit, Vietnam (1) Merck Sharp & Dohme LLC (1)
Get alerts when Molnupiravir trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free